← Leaderboards
Fernando D Martinez
University Of Arizona
$68,375,515
Attributed
$85,375,341
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$107,054,599 · 19
By mechanism
R01$32,947,783 · 5
U01$23,954,599 · 2
P01$20,535,709 · 5
U10$13,704,348 · 2
UH3$6,867,462 · 1
P50$5,528,938 · 2
Top collaborators
- Stefano Guerra13 shared
- Anne L. Wright11 shared
- Monica Kraft7 shared
- Susan Veronica Lynch6 shared
- Cecilia Ballesteros Rosales6 shared
- Donata Vercelli6 shared
- Kurt R Denninghoff5 shared
- Tara F Carr3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Donata Vercelli$11,141,049
- Scott C Carvajal$19,389,166
- Cecilia Ballesteros Rosales$3,741,384
- Maria Elena Martinez$16,585,287
- Kurt R Denninghoff$5,682,950
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
- Joshua A Boyce · Brigham And Women'S Hospital$45,961,764
Research focus
AsthmaChildLifeWheezingParticipantBirthChildhood AsthmaGenetic PolymorphismPhenotypeClinical ResearchResponseRespiratoryGenesSamplingAdultChildhoodHuman SubjectImmuneCohortSymptomsArizonaCellsBaseGenetic
Grant awards (98)
Early Origins of Chronic Lung Disease: From Birth to Age 45 Years$1,774,009
R01 · FY2025 · HL · contact PI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)$1,618,435
UH3 · FY2025 · HL · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$857,995
P01 · FY2025 · AI · contact PI
Administrative Core$122,572
P01 · FY2025 · AI · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$122,570
P01 · FY2025 · AI · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$3,108,703
P01 · FY2024 · AI · contact PI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)$1,723,433
UH3 · FY2024 · HL · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$480,169
P01 · FY2024 · AI · contact PI
Administrative Core$197,321
P01 · FY2024 · AI · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$2,201,214
P01 · FY2023 · AI · contact PI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)$1,760,360
UH3 · FY2023 · HL · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,519,797
R01 · FY2023 · HL · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$541,356
P01 · FY2023 · AI · contact PI
Administrative Core$126,894
P01 · FY2023 · AI · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$3,058,638
P01 · FY2022 · AI · contact PI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)$1,765,234
UH3 · FY2022 · HL · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,517,972
R01 · FY2022 · HL · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$522,310
P01 · FY2022 · AI · contact PI
Administrative Core$167,350
P01 · FY2022 · AI · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$3,035,925
P01 · FY2021 · AI · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,473,403
R01 · FY2021 · HL · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$489,762
P01 · FY2021 · AI · contact PI
Administrative Core$182,914
P01 · FY2021 · AI · contact PI
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application$3,878,301
U01 · FY2020 · HL · contact PI
Binational Early Asthma & Microbiome Study (BEAMS)$3,046,996
P01 · FY2020 · AI · contact PI
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life$1,519,158
R01 · FY2020 · HL · contact PI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)$1,466,425
UG3 · FY2020 · HL · contact PI
Microbiome Influences on Asthma-Related Outcomes in Early Life$736,399
P01 · FY2020 · AI · contact PI
Administrative Core$179,248
P01 · FY2020 · AI · contact PI
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application$5,091,636
U01 · FY2019 · HL · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2019 · HL · contact PI
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application$5,973,284
U01 · FY2018 · HL · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2018 · HL · contact PI
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application$3,900,262
U01 · FY2017 · HL · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,376,435
R01 · FY2017 · HL · contact PI
ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application$3,517,227
U01 · FY2016 · HL · contact PI
Early Origins of Chronic Airflow Limitation: Outcomes Into the 4th Decade of Life$1,408,546
R01 · FY2016 · HL · contact PI
Integrative Health Sciences Core$384,630
P30 · FY2016 · ES · contact PI
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,102,034
R01 · FY2015 · HL · contact PI
Integrative Health Sciences Core$384,631
P30 · FY2015 · ES · contact PI
Arizona/Duke Clinical Center for AsthmaNet$174,854
U10 · FY2015 · HL · contact PI
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,096,440
R01 · FY2014 · HL · contact PI
Arizona/Duke Clinical Center for AsthmaNet$501,452
U10 · FY2014 · HL · contact PI
Integrative Health Sciences Core$384,631
P30 · FY2014 · ES · contact PI
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,053,881
R01 · FY2013 · HL · contact PI
Arizona/Duke Clinical Center for AsthmaNet$862,742
U10 · FY2013 · HL · contact PI
Integrative Health Sciences Core$510,812
P30 · FY2013 · ES · contact PI
Childhood Predictors of Airway Structure, Function, and Disease in Adult Life$1,108,436
R01 · FY2012 · HL · contact PI
Arizona/Duke Clinical Center for AsthmaNet$862,566
U10 · FY2012 · HL · contact PI
Integrative Health Sciences Core$384,631
P30 · FY2012 · ES · contact PI
Arizona/Duke Clinical Center for AsthmaNet$862,566
U10 · FY2011 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$1,079,099
R01 · FY2010 · HL · contact PI
Arizona/Duke Clinical Center for AsthmaNet$862,566
U10 · FY2010 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$1,081,804
R01 · FY2009 · HL · contact PI
Arizona/Duke Clinical Center for AsthmaNet$536,491
U10 · FY2009 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$11,048
R01 · FY2009 · HL · contact PI
CARE Network - Tucson Clinical Center$1,049,157
U10 · FY2008 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$973,814
R01 · FY2008 · HL · contact PI
IL8 and GATA3-mediated Pathways in Asthma Exacerbations$491,093
R01 · FY2008 · HL · contact PI
CARE Network - Tucson Clinical Center$1,128,838
U10 · FY2007 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$970,088
R01 · FY2007 · HL · contact PI
IL8 and GATA3-mediated Pathways in Asthma Exacerbations$501,115
R01 · FY2007 · HL · contact PI
Natural History of Asthma from Birth to Early Adult Life$969,241
R01 · FY2006 · HL · contact PI
IL8 and GATA3-mediated Pathways in Asthma Exacerbations$515,649
R01 · FY2006 · HL · contact PI
CARE Network - Tucson Clinical Center$466,743
U10 · FY2006 · HL · contact PI
SCOR IN CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA$1,178,312
P50 · FY2005 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD$883,221
R01 · FY2005 · HL
IL8 and GATA3-mediated Pathways in Asthma Exacerbations$526,750
R01 · FY2005 · HL
CARE Network - Tucson Clinical Center$512,361
U10 · FY2005 · HL
Gene environment interactions at the begining of asthma$268,627
P50 · FY2005 · HL
SCOR IN CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA$1,315,670
P50 · FY2004 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD$861,796
R01 · FY2004 · HL
CARE Network - Tucson Clinical Center$851,199
U10 · FY2004 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$545,097
R01 · FY2004 · HL
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS$1,855,895
U10 · FY2003 · HL
SCOR IN CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA$1,278,946
P50 · FY2003 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD$840,995
R01 · FY2003 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$545,097
R01 · FY2003 · HL
INNATE IMMUNITY IN HEART, LUNG, AND BLOOD DISEASE$414,160
U01 · FY2003 · HL
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS$1,801,131
U10 · FY2002 · HL
SCOR IN CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA$1,239,486
P50 · FY2002 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD$820,801
R01 · FY2002 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$416,625
R01 · FY2002 · HL
INNATE IMMUNITY IN HEART, LUNG, AND BLOOD DISEASE$403,496
U01 · FY2002 · HL
Gene environment interactions at the begining of asthma$247,897
P50 · FY2002 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$128,472
R01 · FY2002 · HL
SCOR IN CELLULAR AND MOLECULAR MECHANISMS OF ASTHMA$1,357,373
P01 · FY2001 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADULTHOOD$810,196
R01 · FY2001 · HL
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS$736,539
U10 · FY2001 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$416,625
R01 · FY2001 · HL
INNATE IMMUNITY IN HEART, LUNG, AND BLOOD DISEASE$393,143
U01 · FY2001 · HL
GENETIC REGULATION OF IMMUNE MATURATION IN ASTHMA$340,875
R01 · FY2001 · HL
Gene environment interactions at the begining of asthma$0
P01 · FY2001 · HL
LONGITUDINAL STUDY OF ASTHMA FROM BIRTH TO ADOLESCENCE$757,801
R01 · FY2000 · HL
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS$639,248
U10 · FY2000 · HL
CHROMOSOME 5Q GENE VARIANTS AND ASTHMA-RELATED TRAITS$416,625
R01 · FY2000 · HL
INNATE IMMUNITY IN HEART, LUNG, AND BLOOD DISEASE$383,090
U01 · FY2000 · HL
GENETIC REGULATION OF IMMUNE MATURATION IN ASTHMA$340,875
R01 · FY2000 · HL